John Guarino

650 total citations
19 papers, 517 citations indexed

About

John Guarino is a scholar working on Psychiatry and Mental health, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, John Guarino has authored 19 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 4 papers in Anesthesiology and Pain Medicine. Recurrent topics in John Guarino's work include Treatment of Major Depression (4 papers), Anesthesia and Sedative Agents (4 papers) and Schizophrenia research and treatment (4 papers). John Guarino is often cited by papers focused on Treatment of Major Depression (4 papers), Anesthesia and Sedative Agents (4 papers) and Schizophrenia research and treatment (4 papers). John Guarino collaborates with scholars based in United States, Japan and United Kingdom. John Guarino's co-authors include Masaaki Ogasa, Mitsutaka Nakamura, Tatsuya Kimura, Debra Phillips, Antony Loebel, Josephine Cucchiaro, Joseph M. Severs, Kenzie L. Preston, R. R. Griffiths and Barbara C. Wolf and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

John Guarino

19 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Guarino United States	12	299	124	107	86	42	19	517
H. M. Emrich Germany	13	215 0.7×	92 0.7×	79 0.7×	86 1.0×	80 1.9×	27	542
Hidebumi Hazama Japan	13	362 1.2×	87 0.7×	119 1.1×	59 0.7×	46 1.1×	48	597
Patrick E. Ciccone United States	9	368 1.2×	132 1.1×	161 1.5×	146 1.7×	65 1.5×	14	511
Ahmed Elkashef United States	8	344 1.2×	88 0.7×	180 1.7×	56 0.7×	41 1.0×	23	584
Josef Schöpf Switzerland	10	172 0.6×	89 0.7×	83 0.8×	106 1.2×	38 0.9×	27	400
Christian Barnas Austria	13	230 0.8×	115 0.9×	69 0.6×	101 1.2×	70 1.7×	25	515
Neil M. Kurtz United States	11	189 0.6×	71 0.6×	46 0.4×	74 0.9×	50 1.2×	18	393
Hilde Lunde Norway	10	177 0.6×	116 0.9×	52 0.5×	58 0.7×	79 1.9×	16	486
John Scott Carman United States	9	206 0.7×	138 1.1×	55 0.5×	171 2.0×	29 0.7×	15	464
H. A. McClelland United Kingdom	13	300 1.0×	47 0.4×	77 0.7×	68 0.8×	67 1.6×	25	518

Countries citing papers authored by John Guarino

Since Specialization

Citations

This map shows the geographic impact of John Guarino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Guarino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Guarino more than expected).

Fields of papers citing papers by John Guarino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Guarino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Guarino. The network helps show where John Guarino may publish in the future.

Co-authorship network of co-authors of John Guarino

This figure shows the co-authorship network connecting the top 25 collaborators of John Guarino. A scholar is included among the top collaborators of John Guarino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Guarino. John Guarino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Potkin, Steven G., Tatsuya Kimura, & John Guarino. (2015). A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia. Therapeutic Advances in Psychopharmacology. 5(6). 322–331. 27 indexed citations

Ogasa, Masaaki, Tatsuya Kimura, Mitsutaka Nakamura, & John Guarino. (2012). Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study. Psychopharmacology. 225(3). 519–530. 101 indexed citations

Nakamura, Mitsutaka, Masaaki Ogasa, John Guarino, et al.. (2009). Lurasidone in the Treatment of Acute Schizophrenia. The Journal of Clinical Psychiatry. 70(6). 829–836. 164 indexed citations

Ogasa, Masaaki, et al.. (2008). EFFECT OF LURASIDONE ON DEPRESSIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA. Schizophrenia Research. 102(1-3). 277–277. 4 indexed citations

Ogasa, Masaaki, et al.. (2003). SM-13496 in patients with acute exacerbation of schizophrenia: A two-dose double-blind phase II comparison with placebo. Schizophrenia Research. 60(1). 297–297. 3 indexed citations

Guarino, John, et al.. (1997). Ethanol and pentobarbital: Comparison of behavioral and subjective effects in sedative drug abusers.. Experimental and Clinical Psychopharmacology. 5(3). 203–215. 2 indexed citations

Mintzer, Miriam Z., John Guarino, Timothy W. Kirk, John D. Roache, & R R Griffiths. (1997). Ethanol and pentobarbital: Comparison of behavioral and subjective effects in sedative drug abusers.. Experimental and Clinical Psychopharmacology. 5(3). 203–215. 17 indexed citations

Wilcox, Charles S., et al.. (1994). A double-blind, placebo-controlled study comparing mianserin and amitriptyline in moderately depressed outpatients. International Clinical Psychopharmacology. 9(4). 271–280. 13 indexed citations

Griffiths, Roland R., Suzette M. Evans, John Guarino, et al.. (1993). Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1163–1174. 33 indexed citations

10.

Preston, Kenzie L., Barbara C. Wolf, John Guarino, & R. R. Griffiths. (1992). Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability.. Journal of Pharmacology and Experimental Therapeutics. 262(2). 707–720. 38 indexed citations

11.

Tortólani, Anthony J., et al.. (1991). The Effect of High Pressure on Microporous Membrane Oxygenator Failure. Artificial Organs. 15(1). 15–22. 12 indexed citations

12.

Samoriski, Gary M., et al.. (1990). Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.. Journal of Pharmacology and Experimental Therapeutics. 252(3). 1125–1133. 20 indexed citations

13.

Preston, Kenzie L., et al.. (1989). Evaluation of the abuse potential of methocarbamol.. Journal of Pharmacology and Experimental Therapeutics. 248(3). 1146–1157. 21 indexed citations

14.

Guarino, John, et al.. (1989). Comparison of the behavioral effects and abuse liability of ethanol and pentobarbital in recreational sedative abusers.. PsycEXTRA Dataset. 95. 453–4. 4 indexed citations

15.

Wolf, Barbara C., John Guarino, Kenzie L. Preston, & R. R. Griffiths. (1989). Abuse liability of diphenhydramine in sedative abusers.. PubMed. 95. 486–7. 9 indexed citations

16.

Guarino, John, et al.. (1986). Pharmacologic characterization of acute chlordiazepoxide dependence in the rat.. Journal of Pharmacology and Experimental Therapeutics. 239(3). 775–783. 19 indexed citations

17.

Lynch, Christopher J., John Guarino, Richard C. Deth, & Michael L. Steer. (1984). Effect of sucrose feeding on alpha 1-adrenergic responses in rat liver. American Journal of Physiology-Endocrinology and Metabolism. 246(4). E344–E349. 2 indexed citations

18.

Guarino, John, et al.. (1983). Phenobarbital tolerance and physical dependence: Chronically equivalent dosing model. European Journal of Pharmacology. 95(1-2). 21–29. 10 indexed citations

19.

Neumeyer, John L., John F. Reinhard, Werner P. Dafeldecker, et al.. (1976). Aporphines. 14. Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-propylnoraporphine. Journal of Medicinal Chemistry. 19(1). 25–29. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact